Association of MICA-TM and MICB C1_2_A Microsatellite Polymorphisms with Tumor Progression in Patients with Colorectal Cancer
Authors:
Open Access
- 8 April 2009
- journal article
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 29 (4) , 545-554
Abstract
The major histocompatibility complex class I related A (MICA) and MICB molecules are ligands of NKG2D receptors on natural killer cells, gamma/delta T cells, and CD8aß T cells that mediate host antitumor immune response. The role of MICA-TM and MICB C1_2_A alleles in patients with colorectal cancer has not yet been investigated. We have analyzed the MICA-TM and MICB C1_2_A polymorphisms in colorectal cancer patients (n = 79) by polymerase chain reaction amplification, subsequent electrophoresis, and sequencing in comparison to a previously analyzed cohort of healthy controls (n = 306). Allele frequencies obtained for MICA-TM and MICB C1_2_A were compared to histopathological data regarding tumor invasion, disease progression, microsatellite instability, and the presence of KRAS mutations (codon 12) and analyzed for possible impact on tumor-related survival (n = 61). Allele frequencies of MICA-TM and MICB C1_2_A polymorphisms were not different in patients with colorectal cancer in comparison to normal controls. In colorectal cancer patients, MICA-TM A4 allele was directly and MICA-TM A5 allele was inversely associated with lymph node involvement and advanced UICC stages. Tumor-related survival in colorectal cancer patients was significantly reduced in the presence of the MICA-TM A4 allele (p = 0.015). In patients with microsatellite stable tumors, survival was reduced in association with the MICA-TM A4 allele (p = 0.006) and MICA-TM A9 allele (p = 0.034), but increased in patients showing the MICA-TM A5 allele (p = 0.042). Specific MICA-TM alleles seem to influence tumor progression and midterm survival of patients with colorectal cancer, indicating an important role of host innate immune predisposition involving NKG2D mediated antitumor response.Keywords
This publication has 36 references indexed in Scilit:
- NKG2D and Natural Cytotoxicity Receptors Are Involved in Natural Killer Cell Interaction with Self‐Antigen Presenting Cells and Stromal CellsAnnals of the New York Academy of Sciences, 2007
- Lysis of a Broad Range of Epithelial Tumour Cells by Human γδ T Cells: Involvement of NKG2D ligands and T‐cell Receptor‐ versus NKG2D‐dependent RecognitionScandinavian Journal of Immunology, 2007
- Regulation of the expression of MHC class I-related chain A, B (MICA, MICB) via chromatin remodeling and its impact on the susceptibility of leukemic cells to the cytotoxicity of NKG2D-expressing cellsLeukemia, 2007
- In Vivo Expression Pattern of MICA and MICB and Its Relevance to Auto-Immunity and CancerPLOS ONE, 2007
- Decreased NKG2D Expression on CD8+ T Cell Is Involved in Immune Evasion in Patients with Gastric CancerClinical Cancer Research, 2007
- Therapy-induced antibodies to MHC class I chain-related protein A antagonize immune suppression and stimulate antitumor cytotoxicityProceedings of the National Academy of Sciences, 2006
- Generation of Antitumor Responses by Genetic Modification of Primary Human T Cells with a Chimeric NKG2D ReceptorCancer Research, 2006
- MHC Class I–Related Chain A Conjugated to Antitumor Antibodies Can Sensitize Tumor Cells to Specific Lysis by Natural Killer CellsClinical Cancer Research, 2005
- Roles of the NKG2D immunoreceptor and its ligandsNature Reviews Immunology, 2003
- Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICAScience, 1999